2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide

C25H27N5OS — CID 100657413

IUPAC2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide
SMILESO=C(CN1C(=S)N[C@H](c2ccccn2)[C@H]1c1cccn1C1CCCC1)Nc1ccccc1
InChIInChI=1S/C25H27N5OS/c31-22(27-18-9-2-1-3-10-18)17-30-24(21-14-8-16-29(21)19-11-4-5-12-19)23(28-25(30)32)20-13-6-7-15-26-20/h1-3,6-10,13-16,19,23-24H,4-5,11-12,17H2,(H,27,31)(H,28,32)/t23-,24-/m1/s1
InChIKeyUOXVKFFRYFFPBR-DNQXCXABSA-N
MW445.59 g/mol
LogP4.61
Rot. Bonds6

About 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide

2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide (PubChem CID 100657413) has the molecular formula C25H27N5OS and a molecular weight of 445.59 g/mol. Its IUPAC name is 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide.

Molecular Properties

Compound Name2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide
PubChem CID100657413
Molecular FormulaC25H27N5OS
Molecular Weight445.59 g/mol
Exact Mass445.19
IUPAC Name2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide
SMILESO=C(CN1C(=S)N[C@H](c2ccccn2)[C@H]1c1cccn1C1CCCC1)Nc1ccccc1
InChIInChI=1S/C25H27N5OS/c31-22(27-18-9-2-1-3-10-18)17-30-24(21-14-8-16-29(21)19-11-4-5-12-19)23(28-25(30)32)20-13-6-7-15-26-20/h1-3,6-10,13-16,19,23-24H,4-5,11-12,17H2,(H,27,31)(H,28,32)/t23-,24-/m1/s1
InChIKeyUOXVKFFRYFFPBR-DNQXCXABSA-N
XLogP4.61
TPSA62.19 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500445.59
LogP ≤ 54.61
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide?
The IUPAC name of 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide (CID 100657413) is 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide.
What is the SMILES notation for 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide?
The canonical SMILES for 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide is O=C(CN1C(=S)N[C@H](c2ccccn2)[C@H]1c1cccn1C1CCCC1)Nc1ccccc1.
What is the InChIKey of 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide?
The InChIKey is UOXVKFFRYFFPBR-DNQXCXABSA-N. The full InChI is InChI=1S/C25H27N5OS/c31-22(27-18-9-2-1-3-10-18)17-30-24(21-14-8-16-29(21)19-11-4-5-12-19)23(28-25(30)32)20-13-6-7-15-26-20/h1-3,6-10,13-16,19,23-24H,4-5,11-12,17H2,(H,27,31)(H,28,32)/t23-,24-/m1/s1.
What are the key properties of 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide?
2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide has a molecular weight of 445.59 g/mol, XLogP of 4.61, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(4S,5S)-5-(1-cyclopentylpyrrol-2-yl)-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]-N-phenylacetamide is sourced from PubChem (CID 100657413), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).